AstraZeneca lands deals for COVID-19 vaccine development, production

Drug manufacturer AstraZeneca announced Thursday that it had finalized a deal with the Trump administration to develop, produce and distribute a vaccine that officials hope will provide immunity against the coronavirus.Reuters and The Associated Press reported that the company secured an agreement with the U.S. for more than $1 billion, ensuring that around 300 million doses of the vaccine will be produced for the U.S.The vaccine was developed…